Surg-20. first in-human study of a novel device for convection enhanced delivery of topotecan and gadolinium for recurrent gbm: interim results

CONCLUSIONS:This first-in-human experience shows that the CMC provides high volume, backflow resistant CED and demonstrates the value associated with use of a tracer to image infusate distribution.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Vogelbaum, M., Ahluwalia, M., Peereboom, D., Stevens, G., Mohammadi, A., Brewer, C. Tags: SURGICAL THERAPY Source Type: research